Zebrafish Models for Drug Discovery and Therapeutic Validation against Non-Tuberculous Mycobacteria
{{output}}
The incidence of non-tuberculous mycobacteria (NTM) is increasing globally, often surpassing the incidence of new tuberculosis (TB) cases in developed countries. Most NTM are environmental organisms; however, there are a number of opportunistic and pathogenic ... ...
